Printer Friendly

Articles from Pharma (September 1, 2008)

1-32 out of 32 article(s)
Title Author Type Words
Aptuit. Brief article 130
Are you keeping up with the evolution of the QP role? 806
Bilcare. Brief article 130
Compound management: the next focus for outsourcing? Outsourcing has become increasingly popular as pharmaceutical companies have sought to cut fixed costs. Compound management has, however, tended to remain in-house, despite not being a core part of drug discovery. Why, until recently, was this the case? And why are things now beginning to change? Tim Lease and Mike Stock, Biofocus DPI, explain. Lease, Tim; Stock, Mike 1673
Covidien launches performance excipient. Brief article 222
Cultivating cell culture. Grosvenor, Sally Report 2587
Designed for sterility assurance. Magriotis, Nicola 1731
EOA 2008: towards the finishing line: the Olympics may have finished and the medals have all been won; but, for a different set of competitors, those involved in the 2008 European Outsourcing Awards, the competition is very much alive. The front runners are entering the home straight and the pace is fast and furious. Robinson, Kevin 877
Getting the most from outsourcing: Dr Emma Modrate, business development manager for bodycote health Sciences' pharma division, reviews the pitfalls of outsourcing analytical laboratory work. Modrate, Emma 1373
Global pharma a radical departure? 869
How to find a CRA: with the number of clinical trials continuing to rise, there is growing pressure on companies to find, appoint and retain good CRAs (Clinical Research Associates). But finding the right CRA for the job is proving increasingly difficult. Alex Gilmore, Director of recruitment consultants Oxygen Life Science Solutions, explains why CRAs have become such a rare breed. Gilmore, Alex 780
ICSE 2008: making the right connections ... 610
International pros: eclipsing the Tower of Babel: Brittany Bodart, Director of Linguistic Validation, TransPerfect Translations, GALA, highlights some of the problems and solutions for multilingualism in clinical trials. Bodart, Brittany 1607
Just say no counterfeit drugs: Nick Beckett, head of IP and Life Sciences at CMS Cameron McKenna LLP, reviews the problems with counterfeit drugs. Beckett, Nick 806
Larka launches a new portal dedicated exclusively to the pharmaceutical outsourcing industry. Brief article 282
Meeting the challenge of HP-API demand Growth. Feldker, Dave 1391
More packaging flexibility in TEXAS: Allergan's single-use eye drop vials are packaged at their Waco, Texas plant, either in cartons of various sizes, or in hermetically sealed plastic trays. Previously, two separate packaging systems were used for this purpose, but in recent months the American company has implemented a GMP-compliant packaging line, which can do both. 1342
P-MEC 2008: the industry's leading event for machinery and equipment ... 444
Pfizer. Brief article 169
Recipharm moves into lyophilization. Brief article 280
Robust solution for downstream processing of biotherapeutics: faced with tremendous cost pressures, the biomanufacturing industry is looking at options to simplify downstream processing. One solution is second-generation EBA purification alongside the development of disposable chromatography columns. Natalya Clark, Business Development Manager, Upfront Chromatography A/S, discusses these issues. Clark, Natalya 1453
Satellite. Brief article 137
Sea the new drugs? With the need for more APIs, researchers are plumbing the ocean depths in search of new drugs. Andrew Levy reports on the efforts of Nereus Pharmaceuticals. Levy, Andrew 1042
SGS. Dabu, Ferdinand Company overview 568
Sheffield highlights portfolio strength. 666
Sweet applications. 457
That's jazz! At Infinity Pharmaceuticals, individual inspiration sparks a collective performance like none other, and the Cambridge, Massachusetts-based biotechnology company isn't shy about trumpeting its jazz influences--or its bold ambition to beat cancer. Seapy, Sheryl 1426
The evolution of clinical integration: David Stein and Solomon Shacter, ClinPhone, discuss the bebefits of an integrated clinical trial. Stein, David; Shacter, Solomon 2229
Vetter development service. 299
Water: HPW as a low-cost alternative: Peter Wirz, Christ Water Technology Group, reviews the introduction and use of Highly Purified Water (HPW) and suggests that ultrafiltration may harmonize global pharmaceutical water standards. Wirz, Peter 1571
Welcome. Lampard, Graham 228
X-ray analysis tackles unhealthy medicine trade: Dr Detlef Beckers, PANalytical BV, discusses the use of X-ray analysis to detect counterfeit drugs, and its use in stopping these drugs entering the supply chain. Beckers, Detlef 2017

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters